Concepedia

Publication | Open Access

MG1113, a specific anti–tissue factor pathway inhibitor antibody, rebalances the coagulation system and promotes hemostasis in hemophilia

24

Citations

18

References

2020

Year

Abstract

These results indicate that subcutaneous administration of MG1113 neutralizes the function of TFPI and regulates bleeding in individuals with hemophilia.

References

YearCitations

Page 1